{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T17:05:38Z","timestamp":1779555938881,"version":"3.53.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.prp.2026.156517","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:56:16Z","timestamp":1778543776000},"page":"156517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Precursor flat urothelial lesions: Molecular landscape, pathogenesis, and biological insights"],"prefix":"10.1016","volume":"284","author":[{"given":"Fidele Y.","family":"Musangile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibu","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toui","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiyoshi","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9862-3051","authenticated-orcid":false,"given":"Shin-ichi","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.prp.2026.156517_bib1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.prp.2026.156517_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A Consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.prp.2026.156517_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccell.2016.05.004","article-title":"Comprehensive transcriptional analysis of early-stage urothelial carcinoma","volume":"30","author":"Hedegaard","year":"2016","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.prp.2026.156517_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrc3817","article-title":"Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity","volume":"15","author":"Knowles","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.prp.2026.156517_bib5","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/s41379-022-01087-7","article-title":"Flat intraurothelial lesions of the urinary bladder-do hyperplasia, dysplasia, and atypia of unknown significance need to exist as diagnostic entities? and how to handle in routine clinical practice","volume":"35","author":"Paner","year":"2022","journal-title":"Mod. Pathol."},{"issue":"6","key":"10.1016\/j.prp.2026.156517_bib6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1309\/AJCPACNUDWEN9GN4","article-title":"Molecular and immunohistologic analyses cannot reliably solve diagnostic variation of flat intraepithelial lesions of the urinary bladder","volume":"134","author":"Murata","year":"2010","journal-title":"Am. J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2026.156517_bib7","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.path.2022.07.009","article-title":"Update on flat and papillary urothelial lesions: genitourinary pathology society consensus recommendations","volume":"15","author":"Comp\u00e9rat","year":"2022","journal-title":"Surg. Pathol. Clin."},{"key":"10.1016\/j.prp.2026.156517_bib8","series-title":"Classification of Tumors Urinary and male genital tumors","author":"WHO","year":"2022"},{"issue":"9","key":"10.1016\/j.prp.2026.156517_bib9","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1002\/ijc.24619","article-title":"Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development","volume":"125","author":"Zieger","year":"2009","journal-title":"Int J. Cancer"},{"issue":"5","key":"10.1016\/j.prp.2026.156517_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100120","article-title":"Targeted next-generation sequencing of flat urothelial lesions reveals putative pathobiological pathways, potential biomarkers, and rational therapeutic targets","volume":"36","author":"Musangile","year":"2023","journal-title":"Mod. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2026.156517_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109179","article-title":"Multiomics profiling of urothelial carcinoma in situ reveals CIS-specific gene signature and immune characteristics","volume":"27","author":"Anurag","year":"2024","journal-title":"iScience"},{"issue":"Pt 1","key":"10.1016\/j.prp.2026.156517_bib12","first-page":"219","article-title":"Classification of premalignant urothelial abnormalities. A Delphi study of the national bladder cancer collaborative group A","volume":"17","author":"Nagy","year":"1982","journal-title":"Pathol. Annu"},{"key":"10.1016\/j.prp.2026.156517_bib13","first-page":"55","article-title":"Pathology of epithelial tumors & carcinoma in situ of bladder","volume":"162a","author":"Mostofi","year":"1984","journal-title":"Prog. Clin. Biol. Res"},{"key":"10.1016\/j.prp.2026.156517_bib14","article-title":"Tumors of the urinary bladder: atlas of tumor pathology: armed forces institute of pathology","volume":"11","author":"Koss","year":"1975","journal-title":"Fascicle"},{"issue":"5","key":"10.1016\/j.prp.2026.156517_bib15","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0022-5347(17)45204-9","article-title":"Summary of workshop on carcinoma in situ of the bladder","volume":"136","author":"Friedell","year":"1986","journal-title":"J. Urol."},{"issue":"12","key":"10.1016\/j.prp.2026.156517_bib16","first-page":"1435","article-title":"The world health organization\/international society of urological pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder","volume":"22","author":"Epstein","year":"1998","journal-title":"Bladder Consens. Conf. Comm. Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2026.156517_bib17","unstructured":"Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. 3rd Edition ed: WHO Classification of Tumours; 2004."},{"key":"10.1016\/j.prp.2026.156517_bib18","unstructured":"WHO Classification of Tumours of the Urinary System and Male Genital Organs 4th Edition ed: WHO Classification of Tumours; 2016."},{"issue":"4","key":"10.1016\/j.prp.2026.156517_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/PAP.0000000000000308","article-title":"The genitourinary pathology society update on classification and grading of flat and papillary urothelial neoplasia with new reporting recommendations and approach to lesions with mixed and early patterns of neoplasia","volume":"28","author":"Amin","year":"2021","journal-title":"Adv. Anat. Pathol."},{"issue":"8 Pt 2","key":"10.1016\/j.prp.2026.156517_bib20","first-page":"2794","article-title":"Clinical observations on sixty-nine cases of in situ carcinoma of the urinary bladder","volume":"37","author":"Farrow","year":"1977","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.prp.2026.156517_bib21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0022-5347(17)48994-4","article-title":"Significance of carcinoma in situ and dysplasia in association with bladder cancer","volume":"133","author":"Kakizoe","year":"1985","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.prp.2026.156517_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/00365598709180287","article-title":"Urothelial atypia concomitant with primary bladder tumour. incidence in a consecutive series of 500 unselected patients","volume":"21","author":"Wolf","year":"1987","journal-title":"Scand. J. Urol. Nephrol."},{"issue":"3","key":"10.1016\/j.prp.2026.156517_bib23","first-page":"784","article-title":"Two molecular pathways to transitional cell carcinoma of the bladder","volume":"54","author":"Spruck","year":"1994","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.prp.2026.156517_bib24","first-page":"809","article-title":"Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder","volume":"62","author":"Hartmann","year":"2002","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.prp.2026.156517_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ajpath.2019.10.004","article-title":"Next-generation sequencing reveals potential predictive biomarkers and targets of therapy for urothelial carcinoma in situ of the urinary bladder","volume":"190","author":"Garczyk","year":"2020","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2026.156517_bib26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.path.2016.04.004","article-title":"The emerging molecular landscape of urothelial carcinoma","volume":"9","author":"Solomon","year":"2016","journal-title":"Surg. Pathol. Clin."},{"issue":"22","key":"10.1016\/j.prp.2026.156517_bib27","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.prp.2026.156517_bib28","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1158\/0008-5472.CAN-03-3620","article-title":"Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification","volume":"64","author":"Dyrskj\u00f8t","year":"2004","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.prp.2026.156517_bib29","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1038\/s41467-023-41139-3","article-title":"Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ","volume":"14","author":"Yao","year":"2023","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.prp.2026.156517_bib30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.urolonc.2007.12.011","article-title":"The natural history of bladder carcinoma in situ after initial response to bacillus Calmette-G\u00faerin immunotherapy","volume":"27","author":"Gofrit","year":"2009","journal-title":"Urol. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2026.156517_bib31","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1586\/era.10.73","article-title":"The origins of urothelial carcinoma","volume":"10","author":"Cheng","year":"2010","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"1","key":"10.1016\/j.prp.2026.156517_bib32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2026.156517_bib33","series-title":"Biopsy Interpretation of the Bladder","first-page":"448","article-title":"Amin","author":"Jonathan","year":"2023"},{"issue":"1","key":"10.1016\/j.prp.2026.156517_bib34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/his.13762","article-title":"Precursor lesions of the urinary bladder","volume":"74","author":"McKenney","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2026.156517_bib35","series-title":"Biopsy interpretation of the bladder","author":"Epstein","year":"2010"},{"issue":"10","key":"10.1016\/j.prp.2026.156517_bib36","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/1878-0261.12746","article-title":"TERT C228T mutation in non-malignant bladder urothelium is associated with intravesical recurrence for patients with non-muscle invasive bladder cancer","volume":"14","author":"Hayashi","year":"2020","journal-title":"Mol. Oncol."},{"issue":"12","key":"10.1016\/j.prp.2026.156517_bib37","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1136\/jcp.41.12.1277","article-title":"Clinicopathological importance of primary dysplasia of bladder","volume":"41","author":"Zuk","year":"1988","journal-title":"J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2026.156517_bib38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00000478-199904000-00009","article-title":"Natural history of urothelial dysplasia of the bladder","volume":"23","author":"Cheng","year":"1999","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2026.156517_bib39","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<625::AID-CNCR20>3.0.CO;2-A","article-title":"Flat intraepithelial lesions of the urinary bladder","volume":"88","author":"Cheng","year":"2000","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.prp.2026.156517_bib40","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1464-410x.2000.00547.x","article-title":"Long-term follow-up of noninvasive bladder tumours (stage Ta): recurrence and progression","volume":"85","author":"Zieger","year":"2000","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.prp.2026.156517_bib41","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/jcp.41.5.540","article-title":"Flat in situ carcinoma of the bladder: cytological examination of urine in diagnosis, follow up, and assessment of response to chemotherapy","volume":"41","author":"Highman","year":"1988","journal-title":"J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2026.156517_bib42","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.urolonc.2011.01.017","article-title":"Urinary cytology for the detection of urothelial carcinoma of the bladder--a flawed adjunct to cystoscopy?","volume":"31","author":"Bolenz","year":"2013","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.prp.2026.156517_bib43","series-title":"The paris system for reporting urinary cytology","author":"Rosenthal","year":"2015"},{"issue":"5","key":"10.1016\/j.prp.2026.156517_bib44","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.eururo.2006.11.025","article-title":"On the origin of syn- and metachronous urothelial carcinomas","volume":"51","author":"H\u00f6glund","year":"2007","journal-title":"Eur. Urol."},{"issue":"3","key":"10.1016\/j.prp.2026.156517_bib45","first-page":"143","article-title":"Chromosomal abnormalities in macroscopically normal urothelium in patients with bladder pT1 and pT2a urothelial carcinoma: a fluorescence in situ hybridization study and correlation with histologic features","volume":"27","author":"Mazzucchelli","year":"2005","journal-title":"Anal. Quant. Cytol. Histol."},{"issue":"6512","key":"10.1016\/j.prp.2026.156517_bib46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1126\/science.aba7300","article-title":"Macroscopic somatic clonal expansion in morphologically normal human urothelium","volume":"370","author":"Li","year":"2020","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.prp.2026.156517_bib47","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/labinvest.2008.27","article-title":"Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy","volume":"88","author":"Majewski","year":"2008","journal-title":"Lab Invest"},{"issue":"6512","key":"10.1016\/j.prp.2026.156517_bib48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1126\/science.aba8347","article-title":"Extensive heterogeneity in somatic mutation and selection in the human bladder","volume":"370","author":"Lawson","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.prp.2026.156517_bib49","unstructured":"Gonzalez-Perez A.L.-B., Nuria; Risques, Rosa Ana Somatic Mutation in Normal Bladder Study. 2024; phs004105.v1.p1(dbGaP)."},{"issue":"1","key":"10.1016\/j.prp.2026.156517_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0094-0143(05)70229-9","article-title":"The natural history of bladder cancer","volume":"27","author":"Lee","year":"2000","journal-title":"Implic. Ther. Urol. Clin. North Am."},{"issue":"6","key":"10.1016\/j.prp.2026.156517_bib51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.mpdhp.2023.03.007","article-title":"The molecular-morphologic correlates of bladder cancer","volume":"29","author":"Lal","year":"2023","journal-title":"Diagn. Histopathol."},{"issue":"4","key":"10.1016\/j.prp.2026.156517_bib52","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/00313021003767322","article-title":"Papillary urothelial hyperplasia: relationship to urothelial neoplasms","volume":"42","author":"Readal","year":"2010","journal-title":"Pathology"},{"issue":"4","key":"10.1016\/j.prp.2026.156517_bib53","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00428-024-03901-w","article-title":"Comparative analysis of non-coding and coding DNA mutations in flat urothelial lesions: biological implications and insights","volume":"486","author":"Musangile","year":"2025","journal-title":"Virchows Arch."},{"issue":"6","key":"10.1016\/j.prp.2026.156517_bib54","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00345-007-0213-4","article-title":"Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target","volume":"25","author":"Knowles","year":"2007","journal-title":"World J. Urol."},{"issue":"1","key":"10.1016\/j.prp.2026.156517_bib55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.anndiagpath.2013.10.006","article-title":"The role of immunohistochemistry in the diagnosis of flat urothelial lesions: a study using CK20, CK5\/6, P53, Cd138, and Her2\/Neu","volume":"18","author":"Jung","year":"2014","journal-title":"Ann. Diagn. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2026.156517_bib56","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5858\/arpa.2016-0411-OA","article-title":"CK20 and p53 immunohistochemical staining patterns in urinary bladder specimens with equivocal atypia","volume":"142","author":"Arias-Stella","year":"2018","journal-title":"Arch. Pathol. Lab Med"},{"issue":"9","key":"10.1016\/j.prp.2026.156517_bib57","article-title":"Diagnostic roles of immunohistochemical markers CK20, CD44, AMACR, and p53 in urothelial carcinoma in situ","volume":"59","author":"Yoo","year":"2023","journal-title":"Med. (Kaunas. )"},{"issue":"1","key":"10.1016\/j.prp.2026.156517_bib58","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13000-020-00984-2","article-title":"CK20 versus AMACR and p53 immunostains in evaluation of urothelial carcinoma in situ and reactive atypia","volume":"15","author":"Neal","year":"2020","journal-title":"Diagn. Pathol."},{"issue":"5","key":"10.1016\/j.prp.2026.156517_bib59","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.mpdhp.2024.02.001","article-title":"How to distinguish between reactive and neoplastic flat urothelial lesions","volume":"30","author":"Comp\u00e9rat","year":"2024","journal-title":"Diagn. Histopathol."},{"issue":"6","key":"10.1016\/j.prp.2026.156517_bib60","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/ajcp\/aqac117","article-title":"Pathologic image classification of flat urothelial lesions using pathologic criteria-based deep learning","volume":"158","author":"Nishikawa","year":"2022","journal-title":"Am. J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2026.156517_bib61","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ajpath.2022.09.013","article-title":"Use of artificial intelligence for the interpretable prediction of the pathologic diagnosis and molecular abnormalities of flat urothelial lesions","volume":"193","author":"Nishikawa","year":"2023","journal-title":"Am. J. Pathol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T16:46:56Z","timestamp":1779554816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826001706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":61,"alternative-id":["S0344033826001706"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156517","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precursor flat urothelial lesions: Molecular landscape, pathogenesis, and biological insights","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156517","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156517"}}